Nemolizumab – March 2026

Powder for injection containing nemolizumab 30 mg with diluent in pre-filled dual-chamber pen

  • Brand names:
    • Nemluvio®
  • Pharmaceutical Company:
    • GALDERMA AUSTRALIA PTY LTD
  • Condition/Indication: Atopic dermatitis
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026